Academic Journal
RIG-I drives protective type I interferon production by glial cells in response to Neisseria meningitidis and Streptococcus pneumoniae challenge.
| Τίτλος: | RIG-I drives protective type I interferon production by glial cells in response to Neisseria meningitidis and Streptococcus pneumoniae challenge. |
|---|---|
| Συγγραφείς: | Majithia, Krishna J., Johnson, M. Brittany |
| Πηγή: | Frontiers in Immunology; 2025, p1-17, 17p |
| Θεματικοί όροι: | Type I interferons, Bacterial meningitis, Immunologic receptors, Streptococcus pneumoniae, Immune response, Neuroglia, Neisseria meningitidis, Neuroinflammation |
| Περίληψη: | Introduction: Bacterial meningitis is a rapidly progressing and often fatal infection of the central nervous system (CNS), characterized by glial cell activation and potent neuroinflammatory responses. While Toll-like receptors have been well-characterized in CNS immunity, the contribution of cytosolic nucleic acid sensors such as retinoic acid-inducible gene I (RIG-I) remains largely undefined. Although RIG-I is classically associated with initiating antiviral responses, including type I interferon (IFN) production, emerging evidence supports its role in sensing bacterial nucleic acids. Building upon prior findings that bacterial RNA can activate RIG-I in glial cells, we sought to determine the functional contribution of RIG-I during bacterial meningitis. Methods: In this study, we utilized primary murine and immortalized human glial cells to investigate the contribution of RIG-I-mediated responses during N. meningitidis and S. pneumoniae infection. We used immunoblot analysis and specific-capture ELISAs to quantify changes in RIG-I, interferon-stimulated genes, and type I IFN production. To assess the functional role of RIG-I during bacterial infection of glial cells, we employed both siRNA-mediated knockdown and pharmacological inhibition of RIG-I and downstream signaling, respectively. Results: We demonstrate that RIG-I is constitutively expressed in human and murine glial cells and is further upregulated upon bacterial infection, with protein levels varying according to both the bacterial agent and glial cell subtype. Importantly, we show that RIG-I contributes to protective type I IFN responses by glial cells, leading to the restriction of bacterial burden. Additionally, our findings suggest that type I IFN signaling via IFNAR and the resulting induction of ISGs are critical for limiting bacterial survival in glial cells. Excitingly, we have also demonstrated that we can employ RIG-I nucleic acid agonists to augment these protective responses in infected glial cells. Discussion: Our findings establish RIG-I as a key cytosolic sensor that contributes to type I IFN responses in glial cells during bacterial infection of the CNS. By promoting IFNAR-dependent ISG induction, RIG-I signaling contributes to the restriction of bacterial burden. Moreover, our ability to enhance these protective responses using RIG-I agonists highlights the therapeutic potential of targeting this pathway to promote pathogen control during bacterial meningitis. [ABSTRACT FROM AUTHOR] |
| Copyright of Frontiers in Immunology is the property of Frontiers Media S.A. and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) | |
| Βάση Δεδομένων: | Complementary Index |
| FullText | Text: Availability: 0 CustomLinks: – Url: https://resolver.ebsco.com/c/fiv2js/result?sid=EBSCO:edb&genre=article&issn=16643224&ISBN=&volume=&issue=&date=20251202&spage=1&pages=1-17&title=Frontiers in Immunology&atitle=RIG-I%20drives%20protective%20type%20I%20interferon%20production%20by%20glial%20cells%20in%20response%20to%20Neisseria%20meningitidis%20and%20Streptococcus%20pneumoniae%20challenge.&aulast=Majithia%2C%20Krishna%20J.&id=DOI:10.3389/fimmu.2025.1692421 Name: Full Text Finder (for New FTF UI) (ns324271) Category: fullText Text: Full Text Finder MouseOverText: Full Text Finder |
|---|---|
| Header | DbId: edb DbLabel: Complementary Index An: 189736008 RelevancyScore: 1023 AccessLevel: 6 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 1023.09606933594 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: RIG-I drives protective type I interferon production by glial cells in response to Neisseria meningitidis and Streptococcus pneumoniae challenge. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AR" term="%22Majithia%2C+Krishna+J%2E%22">Majithia, Krishna J.</searchLink><br /><searchLink fieldCode="AR" term="%22Johnson%2C+M%2E+Brittany%22">Johnson, M. Brittany</searchLink> – Name: TitleSource Label: Source Group: Src Data: Frontiers in Immunology; 2025, p1-17, 17p – Name: Subject Label: Subject Terms Group: Su Data: <searchLink fieldCode="DE" term="%22Type+I+interferons%22">Type I interferons</searchLink><br /><searchLink fieldCode="DE" term="%22Bacterial+meningitis%22">Bacterial meningitis</searchLink><br /><searchLink fieldCode="DE" term="%22Immunologic+receptors%22">Immunologic receptors</searchLink><br /><searchLink fieldCode="DE" term="%22Streptococcus+pneumoniae%22">Streptococcus pneumoniae</searchLink><br /><searchLink fieldCode="DE" term="%22Immune+response%22">Immune response</searchLink><br /><searchLink fieldCode="DE" term="%22Neuroglia%22">Neuroglia</searchLink><br /><searchLink fieldCode="DE" term="%22Neisseria+meningitidis%22">Neisseria meningitidis</searchLink><br /><searchLink fieldCode="DE" term="%22Neuroinflammation%22">Neuroinflammation</searchLink> – Name: Abstract Label: Abstract Group: Ab Data: Introduction: Bacterial meningitis is a rapidly progressing and often fatal infection of the central nervous system (CNS), characterized by glial cell activation and potent neuroinflammatory responses. While Toll-like receptors have been well-characterized in CNS immunity, the contribution of cytosolic nucleic acid sensors such as retinoic acid-inducible gene I (RIG-I) remains largely undefined. Although RIG-I is classically associated with initiating antiviral responses, including type I interferon (IFN) production, emerging evidence supports its role in sensing bacterial nucleic acids. Building upon prior findings that bacterial RNA can activate RIG-I in glial cells, we sought to determine the functional contribution of RIG-I during bacterial meningitis. Methods: In this study, we utilized primary murine and immortalized human glial cells to investigate the contribution of RIG-I-mediated responses during N. meningitidis and S. pneumoniae infection. We used immunoblot analysis and specific-capture ELISAs to quantify changes in RIG-I, interferon-stimulated genes, and type I IFN production. To assess the functional role of RIG-I during bacterial infection of glial cells, we employed both siRNA-mediated knockdown and pharmacological inhibition of RIG-I and downstream signaling, respectively. Results: We demonstrate that RIG-I is constitutively expressed in human and murine glial cells and is further upregulated upon bacterial infection, with protein levels varying according to both the bacterial agent and glial cell subtype. Importantly, we show that RIG-I contributes to protective type I IFN responses by glial cells, leading to the restriction of bacterial burden. Additionally, our findings suggest that type I IFN signaling via IFNAR and the resulting induction of ISGs are critical for limiting bacterial survival in glial cells. Excitingly, we have also demonstrated that we can employ RIG-I nucleic acid agonists to augment these protective responses in infected glial cells. Discussion: Our findings establish RIG-I as a key cytosolic sensor that contributes to type I IFN responses in glial cells during bacterial infection of the CNS. By promoting IFNAR-dependent ISG induction, RIG-I signaling contributes to the restriction of bacterial burden. Moreover, our ability to enhance these protective responses using RIG-I agonists highlights the therapeutic potential of targeting this pathway to promote pathogen control during bacterial meningitis. [ABSTRACT FROM AUTHOR] – Name: Abstract Label: Group: Ab Data: <i>Copyright of Frontiers in Immunology is the property of Frontiers Media S.A. and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract.</i> (Copyright applies to all Abstracts.) |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=edb&AN=189736008 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.3389/fimmu.2025.1692421 Languages: – Code: eng Text: English PhysicalDescription: Pagination: PageCount: 17 StartPage: 1 Subjects: – SubjectFull: Type I interferons Type: general – SubjectFull: Bacterial meningitis Type: general – SubjectFull: Immunologic receptors Type: general – SubjectFull: Streptococcus pneumoniae Type: general – SubjectFull: Immune response Type: general – SubjectFull: Neuroglia Type: general – SubjectFull: Neisseria meningitidis Type: general – SubjectFull: Neuroinflammation Type: general Titles: – TitleFull: RIG-I drives protective type I interferon production by glial cells in response to Neisseria meningitidis and Streptococcus pneumoniae challenge. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Majithia, Krishna J. – PersonEntity: Name: NameFull: Johnson, M. Brittany IsPartOfRelationships: – BibEntity: Dates: – D: 02 M: 12 Text: 2025 Type: published Y: 2025 Identifiers: – Type: issn-print Value: 16643224 Titles: – TitleFull: Frontiers in Immunology Type: main |
| ResultId | 1 |